Addex Therapeutics Ltd. (ADXN)
Market Open
17 Jun, 17:06
$
6. 44
+0.23
+3.7037%
$
4.68M Market Cap
- P/E Ratio
- Div Yield
6,203 Volume
0 Eps
$ 6.21
Previous Close Want to track ADXN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Addex Therapeutics Ltd. (ADXN) Statistics
Valuation metrics
Market Cap 4.68M
Enterprise value 4.62M
Trailing P/E (ttm) -0.87
Forward P/E -140.6
PEG ratio 0
Price/Sales (ttm) 40.71
Price/Book (mrq) 1.23
Enterprise Value/Revenue 30.23
Enterprise Value/EBITDA -0.8
Overview
Shares outstanding 116.57M
Float 92.72M
Shares short 6.75K
% Held by insiders -
% Held by institutions 0%
Average volume (10 days) 20.95K
Average volume (90 days) 4.86K
Price summary
52-Week low 5.41
52-Week high 12.05
Beta 1.86
50-Day moving average 6.85
200-Day moving average 7.31
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:20
Last split Date 23 Oct 2023
Financials
Fiscal year
Fiscal year ends 31 Dec 2024
Most recent quarter (mrq) 30 Sep 2025
Profitability
Profit margin -43.98%
Operating margin -18.4%
Operational effectiveness
Return on assets -1.06%
Return on equity -1.03%
Income Statement
Revenue (ttm) 203.7K
Revenue per share (ttm) 0
Quarterly revenue growth (yoy) -0.15%
Gross profit (ttm) -675.4K
EBITDA -3.16M
Net income to common (ttm) -7.96M
Diluted EPS (ttm) -0.05
Quarterly earnings growth (yoy) -0.56%
Balance Sheet
Total cash (mrq) 2.81M
Total cash per share (mrq) 0.01
Total debt (mrq) 46.96K
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 1.4%
Book value per share (mrq) 0.03
Cash Flow
Cash flow statement -2.02M
Levered free cash flow (LFCF) -770.72K
